2 "Individuals" Shrouded in Mystery Here, this

New Post Public Reply Private Reply Replies (0) Message Board
biloxiblues
1,042



2 "Individuals" Shrouded in Mystery


Here, this is sort of an addendum to the previous article: The Manifestation of Truth Delivers a Tried & True and an Expected Resultant Outcome.

https://www.reddit.com/r/LeronLimab_Times/com...;context=3

This addendum will attempt to show how important the contribution of David Welch is and how important Sidley Austin's contribution is. That the contributions of these two "individuals" can not be underestimated.

Sidley Austin is a law firm representing CytoDyn in the Arbitration against Amarex; Mark D. Hopson | People | Sidley Austin LLP

while David Welch has massive investments in CYDY who is also the founder of 4-Good Ventures. https://www.4-good.com/ventures-healthcare-filter

Consider the following about these "individuals" and their contribution towards furthering the cause of CytoDyn:

These "individuals" are witnesses. They have seen, experienced and appreciated the power of this molecule in one way or another. David Welch has recognized that the power of Leronlimab is without equal and it has led him to become as heavily invested in CytoDyn as he currently is, and to provide that $6.5M bond in confidence because at worst, he would receive the rights to the molecule himself and build it back on his own. That's the kind of conviction this individual has because he has seen and experienced what it can do. His company of 4-Good Ventures is massively invested. Sidley Austin is a witness to the crimes committed against the company through all the hard and soft evidence they have uncovered. Who is paying this law firm? I have found no evidence that CytoDyn is paying them? Are they doing this for the pay out at the end? There is a powerful motivation for Sidley Austin to take on Amarex in this Arbitration and they are showing strong conviction.

It is on the evidence of two or three witnesses a matter shall be confirmed. Deuteronomy 19:15.

Every fact is to be confirmed by the testimony of two or three witnesses. 2 Corinthians 13:1

With Mr. Welch providing the $6.5 million bond, he has testified towards the validity of Leronlimab. He has placed great trust in the molecule, and in the law firm that represents CytoDyn and the molecule. He knew however, that for whatever reason, if that money was necessary in the end to pay Amarex, then, he would have received rights to the molecule with which, he would then go on to develop it. Today, things have changed and CytoDyn will not lose the patent rights to the molecule even if it is decided that Amarex be paid.

With all their hard work of Discovery over the past year, Sidley Austin has become privy to information which shall reveal the collusion and sabotage executed upon CytoDyn. Sidley Austin has discovered and uncovered certain information that unveils the heavy and weighted cover up of the collusive activity between Amarex and Big Pharma. Sidley Austin obtained and has in their possession, certain information on Amarex and 13D which proves collusion as well as sabotage. They have information on Big Pharma, Big Money and Big Media. They also have information on the FDA. They know what happened. Sidley Austin has the authority to interpret law.

Both of these "individuals" are the perfect candidates that the world could offer who could witness the strength and the power of Leronlimab, one witness in the clinical sense, on how well it performs in the field and one testifying against the sabotage and collusion inflicted upon it in the court room. These "individuals" are utterly massive, completely different from you and I; these individuals are truly massive in their own way, both being heavy hitters of their own kind who can pull in swarms of funding when necessary, and when they speak, like EF Hutton, people shall listen. But, so far, neither has spoken with their mouths, not to the public at least. Neither has said a word. But their actions have spoken volumes. They wait to speak. They wait for their win. They wait for Leronlimab's win. Now wait, the time approaches, when their mouths shall open and their words on behalf of Leronlimab and CytoDyn and upon the injustice which was executed upon this company and its molecule. They will speak also on how treacherous were all the lies and what harm these lies did to humanity as a result of these lies.

When these "individuals" decide to speak, much will be revealed. The very reason Mr. Welch put up $6.5M as surety for the bond. The precise reason why Sidley Austin is waging this arbitrage case against Amarex on behalf of CytoDyn with no promise of payment. The exact means by which Sidley Austin actually became involved and to what depths or to what extent did the Perpetrators go to sabotage CytoDyn and what their motivations and intentions were exactly. So these individuals will have the answers, but when will they speak? and to who will they speak? Well to the shareholders of course and to the world so as to draw them nigh.

We know that Mr. Welch is a huge shareholder who owns and runs a large venture capital company, but as far as I know, Sidley Austin is not a share holder per say. So then, what is Sidley Austin's interest in CytoDyn? Surely Sidley Austin believes that they have a future with CytoDyn in one way or another and I believe that too. Partnership maybe, a share in the profits, or becoming the law firm for CytoDyn? Both David Welch and Sidley Austin are trusted by all of CytoDyn's shareholders for their sheer actions in favor of the company. David Welch has put great faith in Sidley Austin when he put up that $6.5M bond. David Welch and Sidley Austin have the authority and shall stand up together in defense of CytoDyn and in offense against Amarex.

These individuals together shall stand up together against Amarex. And against anyone else who may be dragged into the case who colluded with Amarex. These "individuals" shall speak and make their arguments heard. They will demand justice for all the wrongs perpetrated against CytoDyn, justice for CytoDyn, justice for the share holders, justice for the patients, justice to rule for a fair recompense. There won't be anything left of Amarex, once the dust settles.

To me, it is clear that these individuals have the foresight to see Leronlimab's future. They are able to see what Leronlimab will do for us all and thus, they stand in confidence today, on its side, on its behalf. With their work in this Arbitration and with its successful outcome, these "individuals" help immensely in getting Leronlimab approved and distributed to market and they set a precedent in this case by installing a protection barrier surrounding CytoDyn thereby rendering Lerolimab untouchable by these Perpetrators into the coming years. In addition, these "individuals" shall stand along side with CytoDyn and shall help it to get Leronlimab approved for multiple indications as testified by the work they performed in this case. They shall feed CytoDyn's rapid growth almost like a source of nourishment and shall provide the ways and means for CytoDyn to thrive. Together, the work of David Welch and Sidley Austin imparting their strength into CytoDyn, shall deliver this molecule into the hands of the masses of people, delivering exactly where it is needed most, while protecting it from those who aspire against it.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

U.S. Shipbuilding Gets a Boost with New Defense Vessels

Updated Category News Views 19

No tiptoeing around here, the U.S. is gearing up for a maritime comeback with a fresh contract awarded to TOTE Services and Hanwha Philly Shipyard. They're not just building any old ships; these vessels are set to bolster America's missile defense through the Missile Defense Agency's (MDA) new Missile Range Instrumentation Vessels (MRIV). If you think shipbuilding doesn't...

Continue Reading
Recent Fed Minutes Highlight Interest Rate Discussions Amid Growth

Updated Category News Views 203

Insightful Takeaways from the Federal Reserve Minutes The latest minutes from the Federal Open Market Committee (FOMC) have shed light on the intriguing discussions that took place in September regarding interest rate movements. The meeting revealed a debate among committee members on whether to opt for a 25 basis point reduction or a more aggressive 50 basis point cut....

Continue Reading
Itron's Upcoming Engagement at Key Investor Conference

Updated Category News Views 249

Itron to Participate in Renowned Investor Conference Itron, Inc. (NASDAQ: ITRI), a leader in innovative solutions for utilities and cities aiming to optimize management of energy and water, has announced exciting participation in a pivotal conference focused on energy, power, renewables, and mining. This conference, significant for stakeholders in these sectors, will...

Continue Reading
French Central Bank Urges Fiscal Reform Amid Debt Concerns

Updated Category News Views 91

Tackling France's Fiscal Challenges Recently, Francois Villeroy de Galhau, the Governor of the Bank of France, stressed the urgency of addressing the country's significant deficit and debt issues. He raised concerns about alarming signs emerging from the bond markets, indicating that action is needed. Global Pressures and Interest Rate Shifts While appearing on France 2...

Continue Reading
Wing It On! Strengthens Its Presence with New Franchise in Omaha

Updated Category News Views 291

Wing It On! Launches Franchise in Nebraska As demand for wings continues to rise across the country, Wing It On! proudly announces its exciting debut in a new market. This renowned wing brand has partnered with a seasoned entrepreneur in Omaha, giving them the opportunity to introduce award-winning buffalo wings to a city eager for high-quality wing options. Bill...

Continue Reading